well either way, as you say "In plain English: BRN must apparently achieve unspecified (in the announcement) milestones and have a suitable Akida device before getting any funding."
lol lol
of course this is what we and customers have been waiting for and its here. Regardless of any income for the evaluation we're not after peanuts. All of the NDA's are in the same boat, we're after the bigger prize and a proven physical product is what the customers need and I believe they're receiving these chips in hand as we speak. worst case scenario we move to other potential customers.
We all know the limitless application's available to BRN. All you have to do to believe this is see the wide array of industries we're dipping our toes n shoving our snouts into already.
- Forums
- ASX - By Stock
- BRN
- The Ford and Valeo "deals' appear to be unpaid evaluations
The Ford and Valeo "deals' appear to be unpaid evaluations
-
-
Share
@DrPutin
Two standard car industry evaluations. No money. No binding contract. Virtually no chance of getting a deal.
More cleverly worded bits of fluff from BRN to get the punters excited.
Last edited by PigsMightFly: 20/09/20 - There are more pages in this discussion • 58 more messages in this thread...
Featured News
Add BRN (ASX) to my watchlist
(20min delay)
|
|||||
Last
28.0¢ |
Change
-0.015(5.08%) |
Mkt cap ! $552.2M |
Open | High | Low | Value | Volume |
29.5¢ | 30.0¢ | 27.5¢ | $6.297M | 22.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
44 | 1370975 | 27.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
28.5¢ | 1073647 | 14 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 1320975 | 0.275 |
48 | 1391142 | 0.270 |
14 | 575137 | 0.265 |
16 | 333306 | 0.260 |
7 | 126883 | 0.255 |
Price($) | Vol. | No. |
---|---|---|
0.285 | 1073647 | 14 |
0.290 | 678311 | 14 |
0.295 | 941871 | 17 |
0.300 | 1088061 | 27 |
0.305 | 934255 | 14 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online